Department of Surgery, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
Division of Vascular and Endovascular Surgery, Department of Surgery, UNIFESP - Escola Paulista de Medicina, São Paulo, Brazil.
Cochrane Database Syst Rev. 2021 Apr 28;4(4):CD013702. doi: 10.1002/14651858.CD013702.pub2.
Bypass surgery using a large saphenous vein graft, or another autologous venous graft, is a well-recognised treatment option for managing peripheral arterial disease of the lower limb, including chronic limb-threatening ischaemia (CLTI) and intermittent claudication, peripheral limb aneurysms, and major limb arterial trauma. Bypass surgery has good results in terms of limb preservation rates and long-term graft patency but is limited by the possibility of vein graft failure due to stenoses of the graft. Detection of stenoses through clinical and ultrasonographic surveillance, followed by treatment, is used to avoid graft occlusion. The conventional approach to treatment of patients with graft stenosis following infrainguinal bypass consists of open surgical repair, which usually is performed under general anaesthesia. Endoluminal treatment with angioplasty is less invasive and uses local anaesthesia. Both methods aim to improve blood flow to the limb.
To assess the effectiveness of endoluminal interventions versus surgical intervention for people with vein graft stenosis following infrainguinal bypass.
The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL, the World Health Organization International Clinical Trials Registry Platform, and ClinicalTrials.gov to 25 August 2020.
We aimed to include all published and unpublished randomised controlled trials (RCTs) that compared endoluminal interventions versus surgical intervention for people with vein graft stenosis following infrainguinal bypass.
Two review authors independently assessed all identified studies for potential inclusion in the review. We aimed to use standard methodological procedures in accordance with the Cochrane Handbook for Systematic Reviews of Interventions. The main outcomes of interest were primary patency, primary assisted patency, and all-cause mortality.
We identified no RCTs that met the inclusion criteria for this review.
AUTHORS' CONCLUSIONS: We found no RCTs that compared endoluminal interventions versus surgical intervention for stenosis in vein grafts following infrainguinal bypass. Currently, there is no high-certainty evidence to support the use of one type of intervention over another. High-quality studies are needed to provide evidence on managing vein graft stenosis following infrainguinal bypass.
使用大隐静脉移植物或其他自体静脉移植物进行旁路手术是治疗下肢周围动脉疾病的一种公认的治疗选择,包括慢性肢体威胁性缺血(CLTI)和间歇性跛行、外周肢体动脉瘤和主要肢体动脉创伤。旁路手术在肢体保留率和长期移植物通畅率方面效果良好,但由于移植物狭窄,移植物失败的可能性有限。通过临床和超声监测发现狭窄,并进行治疗,以避免移植物闭塞。治疗下肢旁路术后静脉移植物狭窄患者的传统方法包括开放式修复手术,通常在全身麻醉下进行。腔内血管成形术治疗具有侵入性较小,使用局部麻醉。这两种方法的目的都是改善肢体的血流。
评估腔内干预与手术干预对下肢旁路术后静脉移植物狭窄患者的效果。
Cochrane 血管专业信息员检索了 Cochrane 血管特刊登记册、Cochrane 对照试验中心注册库(CENTRAL)、MEDLINE、Embase、CINAHL、世界卫生组织国际临床试验注册平台和 ClinicalTrials.gov,检索时间截至 2020 年 8 月 25 日。
我们旨在纳入所有比较下肢旁路术后静脉移植物狭窄患者腔内干预与手术干预的已发表和未发表的随机对照试验(RCT)。
两名综述作者独立评估了所有潜在纳入的研究。我们旨在按照 Cochrane 干预措施系统评价手册的标准方法进行。主要结局指标为原发通畅率、辅助原发通畅率和全因死亡率。
我们未发现符合本综述纳入标准的 RCT。
我们未发现比较下肢旁路术后静脉移植物狭窄腔内干预与手术干预的 RCT。目前,没有高质量的证据支持使用一种干预方法而不是另一种。需要高质量的研究来提供下肢旁路术后静脉移植物狭窄的管理证据。